City of Hope Launches Phase I CAR T Therapy Trial based on Scorpion Toxin
City of Hope investigators initiated a Phase I (first-in-man) clinical trial evaluating a (CAR) T cell therapy for glioblastoma (GBM) […]
Abramson Cancer Center Investigators Receive $500K for CAR T-cell Gene Therapy for Prostate Cancer
An elite scientific team developing new CAR T-cell gene therapy treatment for advanced metastatic prostate cancer at Abramson Cancer Center […]
Huntsman Cancer Institute Researchers Pursue Powerful CAR T Therapy for Multiple Myeloma
Researchers at the Huntsman Cancer Institute (HCI) at the University of Utah (U of U) report on a novel way […]
MD Anderson Novel Cell-based Immunotherapy Produces Results for CLL & NHL Patients
MD Anderson Cancer Center led a new cell-based immunotherapy clinical trial demonstrated powerfully positive results for 11 patients with either […]
Astellas to Plug-in-and-Play to Vibrant South San Francisco Immuno-Oncology R&D Ecosystem with Xyphos Buy
Astellas Pharma Inc. acquired Xyphos Biosciences, Inc. to strengthen its immuno-oncology pipeline. With the acquisition Astellas gains Xyphos’ novel and proprietary […]
Research Led by City of Hope’s Bart O. Roep, Ph.D., Advances Personalized Medicine for Children With Type 1 Diabetes
As science continues to advance the understanding of how diseases like cancer and diabetes operate in the human body, the […]
University of Pennsylvania to Report on First CRISPR-based Phase I Safety Study for Cancer Patients in America
A University of Pennsylvania led study team revealed data from this first study involving cancer patients who received cells genetically […]
Fred Hutchinson CAR-T Cell Therapy Shows Results for Patient in Phase I Clinical Trial
Fred Hutchinson Cancer Research Center is an amazing place. At the forefront of combating cancer, recently they recently served as […]
A More Targeted CAR-T Cell-based Therapy for Myasthenia Gravis Moves into Clinical Trial with University of Florida
Emerging biopharmaceutical cell and gene therapy venture Cartesian Therapeutics announced that it has initiated a Phase I/2 clinical trial targeting […]
Center for Immunotherapy, Roswell Park Stands Out
Roswell Park Comprehensive Cancer Center (Roswell Park) believes it is in a unique position to lead innovative immune-oncology clinical research. The […]
